Cargando…

Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies

Considering there are several difficulties and limitations in labeling stem cells using multifunctional nanoparticles (MFNP), the purpose of this study was to determine the optimal conditions for labeling human bone marrow mesenchymal stem cells (hBM-MSC), aiming to monitor these cells in vivo. Thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Nucci, Mariana P., Mamani, Javier B., Oliveira, Fernando A., Filgueiras, Igor S., Alves, Arielly H., Theinel, Matheus H., Rodrigues, Luiz D., Marti, Luciana, Gamarra, Lionel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227698/
https://www.ncbi.nlm.nih.gov/pubmed/35745821
http://dx.doi.org/10.3390/pharmaceutics14061249
_version_ 1784734243583164416
author Nucci, Mariana P.
Mamani, Javier B.
Oliveira, Fernando A.
Filgueiras, Igor S.
Alves, Arielly H.
Theinel, Matheus H.
Rodrigues, Luiz D.
Marti, Luciana
Gamarra, Lionel F.
author_facet Nucci, Mariana P.
Mamani, Javier B.
Oliveira, Fernando A.
Filgueiras, Igor S.
Alves, Arielly H.
Theinel, Matheus H.
Rodrigues, Luiz D.
Marti, Luciana
Gamarra, Lionel F.
author_sort Nucci, Mariana P.
collection PubMed
description Considering there are several difficulties and limitations in labeling stem cells using multifunctional nanoparticles (MFNP), the purpose of this study was to determine the optimal conditions for labeling human bone marrow mesenchymal stem cells (hBM-MSC), aiming to monitor these cells in vivo. Thus, this study provides information on hBM-MSC direct labeling using multimodal nanoparticles in terms of concentration, magnetic field, and period of incubation while maintaining these cells’ viability and the homing ability for in vivo experiments. The cell labeling process was assessed using 10, 30, and 50 µg Fe/mL of MFNP, with periods of incubation ranging from 4 to 24 h, with or without a magnetic field, using optical microscopy, near-infrared fluorescence (NIRF), and inductively coupled plasma mass spectrometry (ICP-MS). After the determination of optimal labeling conditions, these cells were applied in vivo 24 h after stroke induction, intending to evaluate cell homing and improve NIRF signal detection. In the presence of a magnetic field and utilizing the maximal concentration of MFNP during cell labeling, the iron load assessed by NIRF and ICP-MS was four times higher than what was achieved before. In addition, considering cell viability higher than 98%, the recommended incubation time was 9 h, which corresponded to a 25.4 pg Fe/cell iron load (86% of the iron load internalized in 24 h). The optimization of cellular labeling for application in the in vivo study promoted an increase in the NIRF signal by 215% at 1 h and 201% at 7 h due to the use of a magnetized field during the cellular labeling process. In the case of BLI, the signal does not depend on cell labeling showing no significant differences between unlabeled or labeled cells (with or without a magnetic field). Therefore, the in vitro cellular optimized labeling process using magnetic fields resulted in a shorter period of incubation with efficient iron load internalization using higher MFNP concentration (50 μgFe/mL), leading to significant improvement in cell detection by NIRF technique without compromising cellular viability in the stroke model.
format Online
Article
Text
id pubmed-9227698
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92276982022-06-25 Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies Nucci, Mariana P. Mamani, Javier B. Oliveira, Fernando A. Filgueiras, Igor S. Alves, Arielly H. Theinel, Matheus H. Rodrigues, Luiz D. Marti, Luciana Gamarra, Lionel F. Pharmaceutics Article Considering there are several difficulties and limitations in labeling stem cells using multifunctional nanoparticles (MFNP), the purpose of this study was to determine the optimal conditions for labeling human bone marrow mesenchymal stem cells (hBM-MSC), aiming to monitor these cells in vivo. Thus, this study provides information on hBM-MSC direct labeling using multimodal nanoparticles in terms of concentration, magnetic field, and period of incubation while maintaining these cells’ viability and the homing ability for in vivo experiments. The cell labeling process was assessed using 10, 30, and 50 µg Fe/mL of MFNP, with periods of incubation ranging from 4 to 24 h, with or without a magnetic field, using optical microscopy, near-infrared fluorescence (NIRF), and inductively coupled plasma mass spectrometry (ICP-MS). After the determination of optimal labeling conditions, these cells were applied in vivo 24 h after stroke induction, intending to evaluate cell homing and improve NIRF signal detection. In the presence of a magnetic field and utilizing the maximal concentration of MFNP during cell labeling, the iron load assessed by NIRF and ICP-MS was four times higher than what was achieved before. In addition, considering cell viability higher than 98%, the recommended incubation time was 9 h, which corresponded to a 25.4 pg Fe/cell iron load (86% of the iron load internalized in 24 h). The optimization of cellular labeling for application in the in vivo study promoted an increase in the NIRF signal by 215% at 1 h and 201% at 7 h due to the use of a magnetized field during the cellular labeling process. In the case of BLI, the signal does not depend on cell labeling showing no significant differences between unlabeled or labeled cells (with or without a magnetic field). Therefore, the in vitro cellular optimized labeling process using magnetic fields resulted in a shorter period of incubation with efficient iron load internalization using higher MFNP concentration (50 μgFe/mL), leading to significant improvement in cell detection by NIRF technique without compromising cellular viability in the stroke model. MDPI 2022-06-12 /pmc/articles/PMC9227698/ /pubmed/35745821 http://dx.doi.org/10.3390/pharmaceutics14061249 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nucci, Mariana P.
Mamani, Javier B.
Oliveira, Fernando A.
Filgueiras, Igor S.
Alves, Arielly H.
Theinel, Matheus H.
Rodrigues, Luiz D.
Marti, Luciana
Gamarra, Lionel F.
Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies
title Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies
title_full Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies
title_fullStr Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies
title_full_unstemmed Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies
title_short Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies
title_sort optimization of multimodal nanoparticles internalization process in mesenchymal stem cells for cell therapy studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227698/
https://www.ncbi.nlm.nih.gov/pubmed/35745821
http://dx.doi.org/10.3390/pharmaceutics14061249
work_keys_str_mv AT nuccimarianap optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies
AT mamanijavierb optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies
AT oliveirafernandoa optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies
AT filgueirasigors optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies
AT alvesariellyh optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies
AT theinelmatheush optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies
AT rodriguesluizd optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies
AT martiluciana optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies
AT gamarralionelf optimizationofmultimodalnanoparticlesinternalizationprocessinmesenchymalstemcellsforcelltherapystudies